|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowances of $2,043 and $1,473 | ||||||||||||||||||||
| Prepaid expenses and other assets, net | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Inventories - current | ||||||||||||||||||||
| Deferred tax assets – current | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| PROPERTY AND EQUIPMENT: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Machinery and equipment | ||||||||||||||||||||
| Surgical instruments | ||||||||||||||||||||
| Furniture and fixtures | ||||||||||||||||||||
| Facilities | ||||||||||||||||||||
| Projects in process | ||||||||||||||||||||
| Total property and equipment | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Net property and equipment | ||||||||||||||||||||
| OTHER ASSETS: | ||||||||||||||||||||
| Deferred financing and deposits, net | ||||||||||||||||||||
| Deferred financing and other non-current assets, net | ||||||||||||||||||||
| Equity investment | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Non-current inventories | ||||||||||||||||||||
| Product licenses and designs, net | ||||||||||||||||||||
| Patents and trademarks, net | ||||||||||||||||||||
| Customer relationships, net | ||||||||||||||||||||
| Finite lived intangible assets, net | ||||||||||||||||||||
| Product licenses and designs | ||||||||||||||||||||
| Patents and trademarks | ||||||||||||||||||||
| Customer relationships | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| LONG-TERM LIABILITIES: | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Line of credit | ||||||||||||||||||||
| Long-term debt, net of current portion | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY: | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
Loading...
